Protocol for the development and validation procedure of the managing the link and strengthening transition from child to adult mental health care (MILESTONE) suite of measures by Santosh, P. et al.
STUDY PROTOCOL Open Access
Protocol for the development and
validation procedure of the managing the
link and strengthening transition from child
to adult mental health care (MILESTONE)
suite of measures
P. Santosh1,2,3*, L. Adams4, F. Fiori1,2,3, N. Davidović5, G. de Girolamo6, G. C. Dieleman7, T. Franić5, N. Heaney1,
K. Lievesley1, J. Madan8, A. Maras9,10, M. Mastroianni1, F. McNicholas11,12,13,14, M. Paul15,16, D. Purper-Ouakil17,
I. Sagar-Ouriaghli1, U. Schulze18, G. Signorini6, C. Street15, P. Tah15, S. Tremmery19,20, H. Tuomainen15,
F. C. Verhulst10,21, J. Warwick8, D. Wolke15,22, J. Singh1,2, S. P. Singh15,16 and for the MILESTONE Consortium
Abstract
Background: Mental health disorders in the child and adolescent population are a pressing public health concern.
Despite the high prevalence of psychopathology in this vulnerable population, the transition from Child and
Adolescent Mental Health Services (CAMHS) to Adult Mental Health Services (AMHS) has many obstacles such as
deficiencies in planning, organisational readiness and policy gaps. All these factors contribute to an inadequate and
suboptimal transition process. A suite of measures is required that would allow young people to be assessed in a
structured and standardised way to determine the on-going need for care and to improve communication across
clinicians at CAMHS and AMHS. This will have the potential to reduce the overall health economic burden and
could also improve the quality of life for patients travelling across the transition boundary. The MILESTONE
(Managing the Link and Strengthening Transition from Child to Adult Mental Health Care) project aims to address
the significant socioeconomic and societal challenge related to the transition process. This protocol paper describes
the development of two MILESTONE transition-related measures: The Transition Readiness and Appropriateness
Measure (TRAM), designed to be a decision-making aide for clinicians, and the Transition Related Outcome Measure
(TROM), for examining the outcome of transition.
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Methods: The TRAM and TROM have been developed and were validated following the US FDA Guidance for
Patient-reported Outcome Measures which follows an incremental stepwise framework. The study gathers
information from service users, parents, families and mental health care professionals who have experience working
with young people undergoing the transition process from eight European countries.
Discussion: There is an urgent need for comprehensive measures that can assess transition across the CAMHS/
AMHS boundary. This study protocol describes the process of development of two new transition measures: the
TRAM and TROM. The TRAM has the potential to nurture better transitions as the findings can be summarised and
provided to clinicians as a clinician-decision making support tool for identifying cases who need to transition and
the TROM can be used to examine the outcomes of the transition process.
Trial registration: MILESTONE study registration: ISRCTN83240263 Registered 23-July-2015 - ClinicalTrials.gov
NCT03013595 Registered 6 January 2017.
Keywords: Adult mental health services, Child and adolescent mental health services, Europe, Patient reported
outcome measures, Transition, Young persons
Background
In the coming decade, the burden of mental ill health in
children and young people is expected to increase by
50% [1]. A transition from childhood to adulthood can
open new opportunities for young people; however, it
can also be a period of emotional and physical chal-
lenges. For those who are mentally ill, this journey can
be daunting especially when faced with the transition
from a child and adolescent mental health services
(CAMHS) to adult mental health services (AMHS). The
transition boundary represents a precarious point at a
critical life stage for young people and is beset with inad-
equate provision of care [2, 3]. Failure of care at this tran-
sition boundary due to disengagement of services [4, 5]
can have a significant impact on young people and their
subsequent quality of life and contribution to society [6],
for example, conditions that were relatively straightfor-
ward to treat in their early stages becoming entrenched
with adverse social, employment and housing implica-
tions. The transitions of Care from Child and Adolescent
Mental Health Services to Adult Mental Health Services
(TRACK) [7–9] study also showed that the majority of
young people with mental health needs not referred from
CAMHS to AMHS had emotional disorders or neurode-
velopmental disorders [10], suggesting that young people
with these conditions are at most risk of being failed by
healthcare services/falling through the gap.
Despite transition being highlighted by the Depart-
ment of Health in the National Health Service, England
(NHS, England) [11] and the National Institute for
Health and Care Excellence [12] as a key area needing
improvement, there is paucity in the evidence base relat-
ing to models that aim to improve care at the transition
boundary between mental health services. There is also a
lack of shared decision making across different countries
[13] that further hampers the development of such
models. In other geographical regions such as in Canada,
others have shown that engagement methods using
digital approaches i.e., ‘Thought Spot’, a web-based plat-
form that aims to facilitate transition in youth, can be
useful for those in post-secondary settings wishing to ac-
cess mental health services [14]. More recently, another
study is tracking experiences of young people in
CAMHS as they transition through the CAMHS/AMHS
boundary [15]. This Longitudinal Youth in Transition
Study (LYiTS) is important because it would be the first
prospective longitudinal study to assess transition in
North America and together with the findings from the
MILESTONE study would provide important informa-
tion for young people in mental health care as they tran-
sition across the transition boundary. Other work has
explored strategies to improve the transition of margin-
alized youth into adulthood [16]. This study identified
themes that could assist in the transition process. Some
important themes raised in the context of transition
were the engagement of involved parties to improve ser-
vice delivery, the impact of relationships with adults and
engagement with family members.
The need for a robust, standardised model of transi-
tion has been expressed [17–19], especially one which
incorporates an evidence-based decision-making process
for identifying those young people who should make a
transition to AMHS, those who can be managed by
other services [20, 21], and those who could be dis-
charged from CAMHS. Another model has focused on
other factors that could improve the mental health of
young people such as the OnTrackNY, that aims to pro-
vide early intervention services for young people experi-
encing psychosis [22, 23] while others have looked to
address the elements involved in youth seeking treat-
ment for substance abuse [24]. The Transition to Inde-
pendence Process model also addressed factors for
transition aged youth [25]. Taken together these findings
highlight that transition for young people is complex
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and several elements need to be considered. Across Europe
and other regions, there are indications that service
provision at the transition boundary is precarious and
would benefit from the development of such a needs-based
assessment [13, 26, 27]. Empowering clinicians with infor-
mation from an accurate measure focusing on relevant do-
mains will enable a smoother and purposeful process of
transition from CAMHS to AMHS or discharge from men-
tal health services if there is no longer a clinical need.
Current transition-related measures
Measures to evaluate the preparedness of transition have
been examined in young people and adults with chronic
and special healthcare needs [28, 29], however, other
measures to test the effectiveness of transition in com-
munity settings are scarce. Only a few scales have ad-
dressed transitions within mental health services. One
study explored the readiness for the transition of treat-
ment into the community and cited domains such as
housing, treatment engagement, medication use, high-
risk behaviours and substance abuse to help manage as-
sertive community treatment (ACT) team capacity [30].
Another such as the University of North Carolina
(UNC) TR(x)ANSITION Scale [31], is a disease-neutral
tool that can be employed in the clinic to measure the
components of paediatric health care transition to adult
care. This scale has items that are deemed necessary for
the transition process such as self-management, medica-
tion adherence, knowledge of the condition, navigation
of services, social support and community involvement.
Through interviews with hospitalised, chronically ill ado-
lescents, another study focused on independence includ-
ing attendance of hospital appointments and coping
with the condition [32]. Many of the items in this scale
were related to the ‘readiness for transition’ rather than
the appropriateness for transition amongst mental health
populations. Other measures include the continuity of
care in mental health services measure, CONNECT [33],
the Patient Continuity of Care Questionnaire [34] and
the Alberta Continuity of Services Scale - Mental Health
(ACSS-MH) [35]. There are other measures of transi-
tion, yet few of them relate to the mental health care set-
ting. A detailed systematic review on measures of
readiness to transition excluded ones that specifically
targeted mental health or developmental disorders [36].
Another review focused on transition outcomes on men-
tal health [37] but revealed a scarcity of studies with suf-
ficient power, precluding the drawing of any inferences
on the effectiveness of different transition measures.
More recently, in the UK, an intervention has been de-
veloped as a co-production with young people (n = 18)
who had experienced transition or were undergoing
transition [38]. In this study, the anxiety of CAMHS
leavers was underestimated by mental health services, and
most young people viewed the CAMHS transition process
as uncaring, feeling uninvolved or not being adequately in-
formed of the transition process. These findings under-
score the requirement for robust and comprehensive
measures that can assess transition across the CAMHS/
AMHS boundary.
Aim
The MILESTONE (Managing the Link and Strengthen-
ing Transition from Child to Adult Mental Health Care)
project aims to address the significant socioeconomic
and societal challenges related to transition, in part by
developing two transition-related measures for the
MILESTONE study [39]. This paper describes the meth-
odology linked with the development and validation of
these bespoke MILESTONE measures related to transi-
tioning from CAMHS: 1) the Transition Readiness and
Appropriateness Measure (TRAM) for determining
readiness and appropriateness for transition; 2) the
Transition Related Outcome Measure (TROM) for
examining the outcome of transition. The measures are
holistic in both their scope and the process of develop-
ment, to ensure that the young person is seen as more
than a list of symptoms and involves not only clinicians
but also young people and their parents/carers.
Methods
The TRAM and TROM measures were developed (see
Fig. 1) as per guidelines described in the United States
(US) Food and Drug Administration (FDA) Guidance
for Industry Patient-Reported Outcome Measures (US
FDA, 2009) [40]. These guidelines have previously been
used for the development of measures in a rare disease
population [41] and to assess mental health in individ-
uals with autism [42]. This process is stepwise involving
seven stages: 1) literature review, 2) review of items by
experts, 3) focus groups, 4) production of draft scales, 5)
scale testing and revision, 6) translation of scales, and 7)
scale validation. The evaluation of the psychometric
properties was a two-stage process: content validity, con-
struct validity and test-retest reliability was assessed first
using data from approximately 100 participants of the
MILESTONE validation study (Phase 1, MILESTONE
validation study) and responsiveness and interpretability
were assessed subsequently using separate data from the
main MILESTONE study (MILESTONE cohort study
and nested cluster randomised trial). All stages of the
MILESTONE study have been completed.
STAGE 1: literature review for concept identification and
concept elicitation
A search of peer-reviewed publications on transitioning
between mental health services and continuity of care
were used to generate an initial list of items that are
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deemed to be of importance by relevant experts in the
field when considering the transition in a mental health
context. These members were chosen due to their exten-
sive experience of working in and knowledge of transi-
tioning in CAMHS. Based on the literature review,
members of the MILESTONE Consortium also dis-
cussed whether the use of one scale or multiple sub-
scales was appropriate. The free solicitation of informa-
tion during initial focus groups (see next section) also
contributed to concept/item generation.
STAGE 2: review of items by an international expert
panel
Psychologists and psychiatrists from health institutions
across the European Union (EU) (including members of
the MILESTONE Consortium), with experience of tran-
sition, were recruited as an expert panel to provide feed-
back on the original list of scale items. Members of the
MILESTONE consortia helped with a ranking of the
long list and provided feedback on later versions of the
scale.
Fig. 1 Flowchart for TRAM/TROM development and validation. Abbreviations: ~ (approximately); CAMHS (Child and Adolescent Mental Health
Services); MILESTONE (Managing the Link and Strengthening Transition from Child to Adult Mental Health Care); TRAM (Transition Readiness and
Appropriateness Measure); TROM (Transition Related Outcome Measure); YP (Young Person)
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STAGE 3: focus groups
Young people with experience of CAMHS both pre and
post-transition and their parents and carers were re-
cruited to take part in focus groups and pilot testing of
the measures.
Inclusion criteria for focus groups
Young people aged 16 to 19 years who had experience of
working with CAMHS, had no intellectual impairment
(IQ > 70), and had a reasonable fluency in the English
language were eligible. Any parent/carer of a young per-
son with experience of CAMHS was also able to partici-
pate providing they have an IQ above 70 and sufficient
English to contribute to a discussion. Parents were able
to participate without their child also participating.
Mental health professionals were eligible to participate
providing they have worked in a service for young
people with mental health problems; this could be in a
CAMHS service, an AMHS that accepts referrals from
CAMHS or a community organisation.
Exclusion criteria for focus groups
Young people were deemed ineligible if they were under
16 years old, had an intellectual impairment (IQ < 70) or
were considered to be too unwell to participate. If the
participant was not able to (or was expected not to be
able to) complete the questionnaires due to severe phys-
ical disabilities, even with assistance from family members
or a research assistant, or deemed to be too vulnerable by
their clinician, then he/she was not eligible. Furthermore,
if participants did not have a reasonable level of English
they were excluded from the study because a reasonable
level of English was required to discuss the elements of
transition and complete transition-related measures.
Participant selection
The three participant types (patients [young people],
parents/carers and clinicians that have experience of
transition) were recruited through mental health ser-
vices, community organisations and advisory groups in
London and Coventry & Warwickshire using conveni-
ence sampling. Clinicians who were known to the re-
search teams and other clinicians in the selected
organisations were approached to help with recruitment.
They checked young people’s and their parents’/carers’
interest in participation after which a member of the re-
search team contacted them. Study posters were also
displayed in relevant clinic areas.
Information sheets and consent forms were provided
to potential participants, with emphasis that participa-
tion is entirely voluntary. A minimum of 24 h was given
between the provision of information and the actual re-
cruitment of participants, who were asked to sign con-
sent forms. Young people and their parents/carers were
compensated for their time with a £10 high street shop-
ping voucher.
Up to 100 participants, comprising young people with
experience of CAMHS, their families and mental health
care professionals, were involved in focus groups and
pilot testing of the new scales. These participants were
involved in the initial part of the focus groups and test-
re-tested the measures.
Process of focus groups
In the context of NHS England, an NHS Trust is an organ-
isation in the NHS that involves and engages with service
users, patients, public and staff and resides in a particular
geographical area. In the context of this study, focus groups
took place at South London and Maudsley NHS Founda-
tion (SLaM) Trust and Coventry and Warwickshire Part-
nership NHS Trust (CWPT). In each Trust, focus groups
were held for young people, parents/carers, CAMHS clini-
cians and AMHS clinicians with each group comprising of
only one participant type and a maximum of five partici-
pants. Nine (9) focus groups were held, the sessions were
also audio-recorded, and detailed notes were made.
Initially, the focus groups centred on two themes (I)
‘readiness for transition’ and (II) ‘identifying successful tran-
sition’. The purpose of this discussion was to provide mem-
bers of the research team with an idea of what the scales
should be able to capture. Open-ended questions were used
to ascertain the factors that participants consider to be im-
portant when determining whether a young person should
transition from CAMHS to AMHS. Next, participants were
provided with the initial list of items generated from the lit-
erature (and revised in subsequent focus groups) to rank
them on a scale of 1–10, with 1 being unimportant and 10
being very important when deciding on transition. This
same list of items was also presented to the international
expert panel of mental health clinicians with experience in
service user transition from CAMHS.
Analysis of focus groups
All focus groups were audio recorded and transcribed. A
member of the research team throughout took notes.
The transcripts allowed a rapid analysis of the data be-
fore the next focus group. After each focus group, the
results of the importance ratings for each item was ana-
lysed, and any new items generated was added to the list.
Potential scale items relating to transition appropriate-
ness and transition outcome were defined based on con-
sensus agreement with the expert panel from the
MILESTONE consortium.
STAGES 4 & 5: production of draft scales and scale testing
and revision
Next, initial versions of the TRAM and TROM were de-
veloped and discussed, and pilot tested with participants
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in further focus groups. Unstructured qualitative inter-
views were conducted to identify wording and comple-
tion problems and to gain feedback on the inclusion of
items. Members of the MILESTONE Consortium also
held in-depth discussions on the most appropriate pat-
terns of response and measurement options, i.e., Likert
style scales, detailed checklists and standalone items, and
on minimising completion burden. Comments on the
clarity and readability of written item descriptions were
solicited at all focus group sessions. Scale templates (wir-
eframes) were also presented during the focus groups to
see how participants would like the TRAM and TROM
scales to appear on the web-based HealthTracker™ plat-
form. Modification and re-evaluation of measures were
conducted based on feedback. Scales were sent to the
MILESTONE consortia members to check for issues
with the scales such as including items that do not
translate between languages. Lastly, scales containing the
final items were also sent to clinicians, parents, young
person advisors and young people for comment upon
usability, content, and structure.
STAGE 6: translation of scales
Final versions of the scales were then translated from
English into all MILESTONE languages (French, French
[for Belgium], German, Dutch, Dutch [for Belgium],
Croatian and Italian). The process involved translation,
back translation and back translation review by the team
who created the scale. Any inconsistencies detected in
the back-translation review were discussed and amended
to ensure that meanings were consistent across language
versions.
Both scales were developed with versions for young
people, clinicians and parent/carers with similar ques-
tions asked from all participant types. The aim was for
all included items to be stand-alone as they appear singly
when the final version of the scale is displayed digitally.
This was recommended by the MILESTONE consortium
that consisted of an expert panel of psychologists and
psychiatrists from health institutions across the EU, with
knowledge and experience of transition. As far as pos-
sible, all items are worded simply and concisely and
rated over a similar period (e.g., 6 months).
Web-based presentation of the TRAM and TROM on the
HealthTracker™ platform
The web-based health monitoring platform Health-
Tracker™ has been used successfully in other multi-centric
studies [42, 43]. The TRAM and TROM were designed as
user-friendly online assessments that exploited the func-
tionality of the web-based HealthTracker™ platform,
allowing the measures to be completed remotely using de-
velopmentally appropriate interfaces, branching structure
of questions, and allocation of appropriate questionnaires
based on need and time-point in the study. They formed
part of the MILESTONE study assessment package [39].
STAGE 7: scale validation
The validation process of the MILESTONE measures has
been completed. This process was done to ensure that the
developed measures assessed the parameters that they
were designed to (validity) and that they did this consist-
ently (reliability). Additionally, the validation assisted in
improving accuracy, accessibility and minimising comple-
tion burden. All three versions (young person [YP], par-
ent/carer [PC] and clinician [CL]) of the TRAM and
TROM were validated in all the MILESTONE Consor-
tium languages. There were two phases to the validation:
phase 1 (MILESTONE validation study) assessed content
validity, construct validity and phase 2 (MILESTONE co-
hort study and nested cluster randomised trial) assessed
responsiveness and interpretability, and the psychometric
properties. For the first phase, a pilot study was conducted
in the eight MILESTONE countries (United Kingdom,
France, Italy, Netherlands, Germany, Belgium, Ireland,
and Croatia), with further details below.
Sample size
For the preliminary validation of the scales, the total
sample size across the eight countries was calculated to
be approximately 100 participants in each group (i.e.,
100 young people, 100 parents/carers/spouses, and 100
mental health professionals), which was based on sample
size calculations.
The power calculations linked with the external validation
have been described in the protocol paper for the MILE-
STONE study [39]. For the analysis of external validity, all
participants in the MILESTONE study (the cohort and con-
trol arms) participated, resulting in a group of approxi-
mately 3000 participants (1000 YP, 1000 PC and 1000 CL).
Recruitment targets
For the first phase of validation, each participant country
was to recruit 15 young people alongside 15 parents/
carers/spouses and 15 mental health care professionals;
from these 15-young people, at least 10 should have tran-
sitioned from CAMHS to AMHS within 18months. The
remaining five participants could be from either group.
For the second phase of validation, different inclusion
targets for young people (and associated parents/carers
and clinicians) were set for each participant country, de-
pending on the number of CAMHS clusters included in
the MILESTONE study [39].
Analyses plan
Quantitative data is being analysed using the latest ver-
sion of the SPSS statistical package (IBM SPSS Statistics
for Windows. Armonk, NY: IBM Corp.).
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Phase 1 of validation
Content validity
The content validity of the TRAM and TROM was
assessed to see whether the items and response options
are relevant measures of the construct.
Criterion validity
The discriminative power (validity) of both scales were
assessed. The primary outcome measure of the MILE-
STONE study is health status as measured by Health of
the Nation Outcome Scale for Children and Adolescents
(HoNOSCA) [44] whose content validity has been estab-
lished [45, 46]. For this study, the newly developed scales
were compared against other standard scales such as the
HoNOSCA (self-rate and clinician-rated versions) meas-
ure as well as other scales namely the Clinical Global
Impression-Severity (CGI-S) and improvement (CGI-I)
scales [47] using the Pearson’s product moment correl-
ation coefficient. The specific subscale scores of the de-
veloped transition scales were also analyzed using
Pearson’s correlation coefficients to see whether they
correlate to the Specific Levels of Functioning (SLOF)
scale (parent-rated).
Internal consistency
Cronbach’s alpha for summary scores were calculated
for the TROM and TRAM. Alpha (α) values of 0.80 or
higher are commonly accepted as evidence of adequate
internal consistency [48]. If relevant, ‘alpha if deleted
analyses’ was also performed to see if removing any po-
tential item(s) from the scales, would reinforce the
measures.
Test-retest reliability
The correlation coefficients between Timepoint 0 (TP0)
(first completion) and TP1a (the second completion was
done within ≤41 days of first assessment) were calculated
using ANOVA. Inter-rater reliability of scales from dif-
ferent raters at the respective time points was computed
(the second completion was done within ≤41 days of first
assessment [TP1a]).
Phase 2 of validation
Responsiveness and interpretability
The responsiveness and interpretability of the TRAM
and TROM were assessed using data obtained from the
main MILESTONE study, with a total of approximately
1000 young people and associated parents/carers and
CAMHS and AMHS clinicians recruited at baseline [39]
after data collection for the main study had been com-
pleted. Statistical analysis was done to obtain a final fac-
tor structure, sensitivity, specificity and predictive value
of the TRAM and TROM. Exploratory factor analyses
(EFA) (principal axis, Promax rotation) was performed
on the different versions of the TROM and TRAM
subscales.
After analysing the data, the scales were optimised, by
checking to see if any items could be dropped from the
scales to make them simpler. The predictive validity of
TRAM was also assessed, by performing statistical ana-
lyses to identify discriminators of successful and unsuc-
cessful transition, and a MILESTONE Transition
Predictor was developed from the final version of
TRAM. This transition predictor is formatted similar to
a traffic light scoring system and allows the development
of future analytics to look at data across all time points
at the end of the study and whether the outcomes of
transition can be predicted based on symptom profile.
Discussion
This study protocol reports the development of two tran-
sition related measures: the TRAM and TROM. These
measures are web-based measures on the HealthTracker™
platform and were translated into eight European lan-
guages and are being tested in eight EU countries in a
two-phase process. The first phase involved approximately
100 young people and covered construct validity, content
validity, and test-retest validity. The second phase involved
over 1000 young people to test responsiveness and inter-
pretability. The development and validation of the TRAM
and TROM has been completed.
As the HealthTracker™ based TRAM and TROM mea-
sures are web-based, they have the potential to be used
worldwide by end users thereby contributing to a
smoother transition process and allowing for persona-
lised mental health care and have added value in inform-
ing the transition process from CAMHS to AMHS. The
findings from these measures will be presented in meet-
ings and conferences and published in scientific journals.
A MILESTONE specific website has already been estab-
lished to facilitate dissemination activities (http://mile-
stone-transitionstudy.eu).
A potential limitation of this study is that the study fo-
cuses on a population which is difficult to recruit (ado-
lescent mental health service users). Furthermore,
participants with the poorest health may be least likely
to respond, or most likely to have missing data.
In summary, the TRAM and TROM measures are
novel in the sense that they can be provided to clinicians
as a decision-making support tool to identify cases that
need to transition and the outcomes of it. This will in-
crease our understanding of the transition process.
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